Haddadin Yezan Munther bought OTLK

May 26, 2026 · Form 4 insider transaction

Haddadin Yezan Munther bought 34,000 shares of Outlook Therapeutics, Inc. at $0.44 per share, a transaction worth $15.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.